Date Filed | Type | Description |
04/06/2023 |
4
| Gibbs Michael Terrence (General Counsel) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Sold 239 shares
@ $0.481, valued at
$115 |
|
04/05/2023 |
4/A
| Gibbs Michael Terrence (General Counsel) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Exercised 334 restricted stock units
@ $0 |
|
03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/09/2023 |
4
| Gibbs Michael Terrence (General Counsel) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Sold 2,145 shares
@ $0.65, valued at
$1.4k
Sold 1,585 shares
@ $0.59, valued at
$935.2 Exercised 4,000 restricted stock units
@ $0 Exercised 2,914 restricted stock units
@ $0 |
|
04/11/2022 |
4
| Gibbs Michael Terrence (General Counsel) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Bought 10,000 shares
@ $0.49, valued at
$4.9k
|
|
03/28/2022 |
4
| Gibbs Michael Terrence (General Counsel) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Paid exercise price by delivering 8,790 shares
@ $0.4409, valued at
$3.9k
Exercised 16,666 restricted stock units
@ $0 |
|
03/28/2022 |
4/A
| Gibbs Michael Terrence (General Counsel) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Paid exercise price by delivering 76,867 shares
@ $0.4488, valued at
$34.5k
Exercised 145,719 restricted stock units
@ $0 |
|
03/28/2022 |
4/A
| Gibbs Michael Terrence (General Counsel) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Paid exercise price by delivering 5,275 shares
@ $0.466, valued at
$2.5k
Granted 600,000 restricted stock units
@ $0 Exercised 10,000 restricted stock units
@ $0 |
|
02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/23/2022 |
4
| Gibbs Michael Terrence (General Counsel) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Paid exercise price by delivering 5,275 shares
@ $0.466, valued at
$2.5k
Granted 600,000 restricted stock units
@ $0 Exercised 10,000 restricted stock units
@ $0 |
|
03/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/26/2020 |
4
| Gibbs Michael Terrence (General Counsel) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Granted 100,000 options to buy
@ $0.39, valued at
$39k
Granted 50,000 restricted stock units
@ $0 |
|
02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/05/2020 |
4
| Gibbs Michael Terrence (General Counsel) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Sold 3,283 shares
@ $0.88, valued at
$2.9k
|
|
09/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/24/2018 |
4
| Gibbs Michael Terrence (General Counsel) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Paid exercise price by delivering 7,824 shares
@ $6.72, valued at
$52.6k
|
|
06/29/2018 |
4
| Gibbs Michael Terrence (General Counsel) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Exercised 24,086 shares
@ $0 |
|
06/08/2018 |
4
| Gibbs Michael Terrence (General Counsel) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Sold 2,202 shares
@ $4.28, valued at
$9.4k
Granted 14,499 shares
@ $0 Paid exercise price by delivering 4,705 shares
@ $8.53, valued at
$40.1k
|
|
03/19/2018 |
4
| Gibbs Michael Terrence (General Counsel) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Granted 96,344 options to buy
@ $0 |
|
03/12/2018 |
4
| Gibbs Michael Terrence (General Counsel) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Granted 90,000 options to buy
@ $5.08, valued at
$457.2k
|
|
06/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |